Hydroxyurea inhibits degradation of internalized epidermal growth factor in HeLa cells.
D000970:Antineoplastic Agents / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects; D004815:Epidermal Growth Factor / Q000378:metabolism*; D066246:ErbB Receptors; D005467:Floxuridine / Q000494:pharmacology; D006367:HeLa Cells / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology*; D007700:Kinetics; D014176:Protein Biosynthesis / Q000187:drug effects; D011956:Receptors, Cell Surface / Q000378:metabolism*; D014158:Transcription, Genetic / Q000187:drug effects
D000970:Antineoplastic Agents; D011956:Receptors, Cell Surface; D005467:Floxuridine; D003561:Cytarabine; D004815:Epidermal Growth Factor; D003513:Cycloheximide; D066246:ErbB Receptors; D006918:Hydroxyurea